• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, September 28, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Many patients with iNPH develop Alzheimer’s disease, too

Bioengineer by Bioengineer
November 15, 2019
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: University of Eastern Finland


Up to one in five patients treated for idiopathic normal pressure hydrocephalus, iNPH, also develop Alzheimer’s disease, according to a new study from the University of Eastern Finland and Kuopio University Hospital. The researchers were able to predict the development of Alzheimer’s disease by using the Disease State Index, DSI, that combines patient-specific data from various sources. The results were published in Journal of Alzheimer’s Disease.

In iNPH, the circulation of cerebrospinal fluid (CSF) is disturbed for an unknown reason, leading to a slightly elevated brain pressure and dilation of the brain ventricles. Symptoms of NPH include gait deviations, impaired short-term memory and urinary incontinence. Patients with iNPH often have changes in brain that are related to Alzheimer’s disease.

The study followed patients with iNPH after they had received treatment for their disease. They were treated with shunt surgery, in which excessive CSF is led from the brain ventricles to the abdominal cavity by using a CSF shunt. Shunted NPH patients who had undergone brain tissue biopsy in connection with their surgery were selected for the study. The objective of the biopsy was to detect changes that are indicative of Alzheimer’s disease.

During the follow-up, the researchers found that up to one in five patients with NPH were later diagnosed with Alzheimer’s disease. At the end of the follow-up, patients with NPH were more frequently diagnosed with Alzheimer’s disease than the general population. The researchers were able to predict the development of Alzheimer’s disease, with moderate accuracy, by using patient-specific DSI. The data used in DSI included the patient’s pre-surgery symptom profile, brain tissue samples and brain MRI images.

###

For further information, please contact:

PhD Student Antti Luikku, MD, tel. +358442909918, antti.luikku (a) uef.fi

Research article:

Luikku et al. Predicting Development of Alzheimer’s Disease in Patients with Shunted Idiopathic Normal Pressure Hydrocephalus. Journal of Alzheimer’s Disease 71 (2019) 1233-1243. DOI 10.3233/JAD-190334

Media Contact
Antti Luikku
[email protected]
358-442-909-918

Related Journal Article

http://dx.doi.org/10.3233/JAD-190334

Tags: AlzheimerMedicine/Healthneurobiology
Share12Tweet8Share2ShareShareShare2

Related Posts

Trunk Control May Hold a Key to Balance and Fall Risk in Older Adults

September 27, 2026

AI Tells Doctors When It Is Unsure About Cancer Treatment Success

September 27, 2026

When Autism Diagnoses Fade: Early Intervention and Milder Symptoms Mark Children Who Lose the Label

September 27, 2026

Weight-Loss Drugs Are Redrawing the Map of Sleep Medicine

September 27, 2026
Please login to join discussion

POPULAR NEWS

  • Trunk Control May Hold a Key to Balance and Fall Risk in Older Adults

    29 shares
    Share 12 Tweet 7
  • AI Tells Doctors When It Is Unsure About Cancer Treatment Success

    29 shares
    Share 12 Tweet 7
  • Engineered mini CRISPR enzyme gets a 60-fold power boost for gene editing

    29 shares
    Share 12 Tweet 7
  • When Autism Diagnoses Fade: Early Intervention and Milder Symptoms Mark Children Who Lose the Label

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Trunk Control May Hold a Key to Balance and Fall Risk in Older Adults

AI Tells Doctors When It Is Unsure About Cancer Treatment Success

Engineered mini CRISPR enzyme gets a 60-fold power boost for gene editing

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.